MedTrace Logo

Postdural Puncture Headache Relief With Aminophylline and SPGB

NCT05552404 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2023-01-11

No results posted yet for this study

Summary

The purpose of the study is to compare Sphenopalatine ganglion block (SPGB) and aminophylline in the efficacy and safety management of PDPH.

Conditions

  • Anesthesia

Interventions

OTHER

conservative therapy

bed rest, fluids, abdominal binder, oral paracetamol, and caffeine

DRUG

Aminophylline

conservative therapy plus Aminophylline (250mg of Aminophylline dissolved in 100ml normal saline for intravenous infusion over 30 minutes)

PROCEDURE

trans nasal sphenopalatine ganglion block

conservative therapy plus sphenopalatine ganglion block SPGB using hollow cotton swab and lidocaine 2%

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • tamer S abdelaziz, MD · Faculty of medicine, Ain Shams University, Cairo, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2022-12-30
Completion
2022-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05552404 on ClinicalTrials.gov